Biogen Wants MS Drug Approved Globally, CEO Says

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)
U.K. Election 'Unbelievably Tight': YouGov CEO
57:07 - Stephan Shakespeare, chief executive officer of London-based YouGov Plc, talks about the polling company's business strategy and the U.K. election. He speaks from Singapore with Rishaad Salamat on Bloomberg Television's "Asia Edge." (Source: Bloomberg)
  • Japan, U.S. Fail to Seal Trade Deal
  • Trichet Says 'Nobody Is Optimistic' on Greece
  • Jaguar Accuses Chinese Automaker of Copying Cars